https://www.selleckchem.com/pr....oducts/finerenone.ht
Budesonide was included in the European Baseline Series in 2000 as the most suitable marker forcorticosteroid hypersensitivity. In the last two decades, a decreasing trend of budesonide allergy has been observed. To estimate the prevalence of positive patch test reactions to budesonide in a large, Italian patch test population, characterizing patients according to MOAHLFA index and evaluating the benefit with extended readings of budesonide patch test. Retrospective analysis of patient demographics and patch test results over a 2-yea
Like
Comment
Share
